**Exciting News: Independent Review Confirms AMBLE's Effectiveness for Foot Drop Therapy!**
We are thrilled to share some remarkable news regarding our recent AMBLE clinical trial! After a thorough evaluation by an independent third-party reviewer, the results have been validated, highlighting the effectiveness, safety, and tolerability of AMBLE as a *therapy* for foot drop.
Foot drop, a common condition following a stroke, can significantly impact mobility and quality of life. Our clinical trial focused on patients who had experienced a stroke, with an average time post-stroke of 9 years. This long duration underscores the challenges faced by individuals living with the effects of stroke, making our findings even more significant.
The independent analysis concluded that AMBLE is not only an "effective, safe, and tolerable therapy for foot drop," but it also revealed some exciting additional benefits. While our primary focus is on the foot and ankle, the review reported statistically significant improvements at the proximal joints, specifically the hip and knee. This finding suggests that our therapy may have broader implications for enhancing overall mobility and function in patients with foot drop.
We are incredibly proud of these results, as they validate the hard work and dedication of our team, as well as the commitment of the participants in our study. The positive feedback from the independent review reinforces our belief in the potential of AMBLE to transform the lives of those affected by foot drop.
As we move forward, we remain committed to further research and development to ensure that AMBLE continues to provide effective solutions for individuals living with the challenges of foot drop. We are excited about the future and look forward to sharing more updates as we continue our journey.
Thank you for your support as we strive to make a difference in the lives of those affected by stroke and foot drop. Stay tuned for more news and developments from our team!
#AMBLE #FootDrop #StrokeRecovery #ClinicalTrial #IndependentReview #RehabRobotics
Recent AMBLE Clinical Trial Independently Reviewed!